Poster Presented Virtually at SNMMI
A poster entitled "A unique theranostic isotope and targeting molecule to treat equine laminitis" was presented virtually at the Society of Nuclear Medicine and Molecular Imaging from July 13 to 16.
A poster entitled "A unique theranostic isotope and targeting molecule to treat equine laminitis" was presented virtually at the Society of Nuclear Medicine and Molecular Imaging from July 13 to 16.
A publication entitled "Radiation Safety Considerations in the Treatment of Canine Skeletal Conditions Using 153Sm, 90Y, and 117mSn" was published in the Journal of Health Physics.
Five abstracts or presentations presented at 10ICI related to Sn-117m including "Harnessing Sn-117m for improved quality of life", "Electron therapy hormesis in inflammatory vascular disease", “Localizing apoptosis-inducing Sn-117m to brain neuroinflammatory cells”, “A new radioisotope-based treatment for veterinary and human…
A human clinical trial using a new high specific activity formulation of tin-117m-DTPA has been accepted into the National Cancer Institute Experimental Therapeutics program and Serene will receive significant support, beginning with a Phase 1 trial in patients with bone…
The following article is in press: Wendt RE, Selting KA, Lattimer JC, Wong J, Simon J, Stevenson NR, Stearns SD. Radiation safety considerations in the treatment of canine skeletal conditions using 153Sm, 90Y and 117mSn. Operational Radiation Safety.
Three abstracts were presentation to the European Association of Nuclear Medicine: oral presentation of "A Novel Sn-117m Colloid for Human Radiosynoviorthesis Clinical Trials", abstract presentation of "Radiosynoviorthesis Using Sn-117m Colloid to Treat Canine Elbow Osteoarthritis Demonstrates Efficacy and Safety", and…
Three abstracts entitled “Localizing apoptosis-inducing Sn-117m to brain neuroinflammatory cells”, “A new radioisotope-based treatment for veterinary and human arthritis”, and "Production of Sn-117m in the BR2 high-flux reactor" were accepted as platform presentations to 10 ICI, February 3-7, Kuala Lampur, Malaysia.…
Serene has received authority to proceed with its first-in-human RSO Phase 1b trial in Canada, by Health Canada. The "No Objection Letter" from the Biologics and Genetic Therapies Directorate authorizes Serene to begin preparations for the trial with prospective clinical…
Two abstracts were submitted to the 10th International Conference on Isotopes on February 3-7, 2020, in Kuala Lampur. They are entitled, "“A new radioisotope-based treatment for veterinary and human arthritis” by Gilbert Gonzales, and “A Novel Sn-117m Colloid for Human…
An electronic publication entitled "Intraarticular injection of a tin-117m radiosynoviorthesis agent in normal canine elbows causes no adverse effects" by lead author Jimmy C Lattimer, DVM, appeared in Veterinary Radiol Ultrasound, 2019; Sep:60(5):567-574